申请人:Rhone-Poulenc Industries
公开号:US04419356A1
公开(公告)日:1983-12-06
Thiazolo[3,2-a]pyrimidine derivative of the formula: ##STR1## wherein R represents phenyl, alkyl of 1 through 4 carbon atoms, alkyl of 1 through 4 carbon atoms substituted by 1 through 3 halogen atom, alkenyl of 2 through 4 carbon atoms, or cycloalkyl of 3 through 6 carbon atoms and R.sub.1 represents hydrogen, or R and R.sub.1 each represent phenyl or unsubstituted alkyl of 1 through 4 carbon atoms, or R and R.sub.1 together represent an alkylene radical of 4 or 5 carbon atoms, and R.sub.2 and R.sub.3 each represent hydrogen or unsubstituted alkyl of 1 through 4 carbon atoms, or R and R.sub.1 each represent hydrogen, and one of R.sub.2 and R.sub.3 represents hydrogen and the other represents unsubstituted alkyl of 1 through 4 carbon atoms, or R.sub.2 and R.sub.3 both represent unsubstituted alkyl of 1 through 4 carbon atoms, are new compounds possessing pharmacological properties. They are especially useful in the treatment of rheumatic disease or allergic states, or as analgesics. Processes for the preparation of the compounds are described.
该化合物为Thiazolo [3,2-a]吡咯嘧啶衍生物,其化学式为:##STR1## 其中R代表苯基,1至4个碳原子的烷基,1至4个碳原子的烷基被1至3个卤素原子取代,2至4个碳原子的烯基或3至6个碳原子的环烷基,R.sub.1代表氢,或R和R.sub.1各自代表苯基或未取代的1至4个碳原子的烷基,或R和R.sub.1一起代表4或5个碳原子的烷基,R.sub.2和R.sub.3各自代表氢或未取代的1至4个碳原子的烷基,或R和R.sub.1各自代表氢,而R.sub.2和R.sub.3中的一个代表氢,另一个代表未取代的1至4个碳原子的烷基,或R.sub.2和R.sub.3都代表未取代的1至4个碳原子的烷基,是具有药理学特性的新化合物。它们在治疗风湿病或过敏状态或作为镇痛剂方面特别有用。描述了制备该化合物的过程。